IDEX(US:IEX)2026-02-04 15:02Financial Data and Key Metrics Changes - IDEX delivered organic revenue growth of 1% in Q4 2025, with adjusted EBITDA margin expanding by 40 basis points year-over-year [16][19] - Free cash flow for the full year 2025 was $617 million, a 2% increase compared to the previous year, with a free cash flow conversion rate of 103% of adjusted net income [19][23] - Adjusted EPS for Q4 came in higher than the guided range, reflecting strong performance [16][19] Business Line Data and Key Metrics Changes - Health and Science Technology (HST) segment saw organic orders increase by 34% and revenue grow by 5%, driven by demand in data centers and semiconductor applications [12][20] - Fluid and Metering Technologies (FMT) experienced organic orders growth of 4% and organic sales growth of 1%, with strong performance in municipal water but softness in chemical and energy markets [13][20][21] - Fire and Safety Diversified Products (FSDP) had flat organic orders and a 5% decline in organic sales, with growth in North American fire OEM offset by weakness outside the U.S. [22] Market Data and Key Metrics Changes - The municipal water-facing businesses within FMT grew mid-single digits, supported by increased capital spending on infrastructure [90] - The general industrial landscape remains flattish, with no significant signs of demand improvement, although there is an emerging consensus that 2026 may see a return to growth [14][15] Company Strategy and Development Direction - IDEX is focusing on expanding and integrating capabilities in targeted advantage markets through its 80/20 playbook, which supports organic growth and M&A [7][29] - The company aims to maintain a balanced capital deployment strategy, focusing on organic investments, M&A, and returning capital to shareholders [23][24] Management's Comments on Operating Environment and Future Outlook - Management noted that while there are signs of order strength, particularly in HST, there has not yet been a clear inflection point in demand across all sectors [15][36] - The outlook for 2026 includes expected organic growth of 1%-2%, with mid-single-digit growth anticipated for HST and flat to slightly down outlooks for FMT and FSDP [25][26] Other Important Information - IDEX completed a small acquisition of Micro-LAM, which is expected to contribute positively to growth in 2026 [10] - The company ended 2025 with strong liquidity of approximately $1.1 billion and repurchased nearly $250 million worth of shares during the year [19][23] Q&A Session Summary Question: Demand outlook based on PMI and order size - Management acknowledged the recent PMI improvement but noted that they have not yet seen a corresponding inflection in demand, with steady order rates but no significant upward movement [34][35] Question: Fresh perspective on IDEX's operations - The new CFO highlighted the strong financial foundation of IDEX and expressed focus on M&A strategy and execution to drive growth [38][39] Question: Price contribution to top line growth - Price contributed approximately 3% to overall growth in 2025, with expectations for a decrease to 0.0% to 0.2% in 2026 [45][46] Question: Disconnect between order strength and revenue conversion - Management explained that while orders have been strong, revenue conversion may lag due to seasonal factors and the nature of longer-cycle applications [54][56] Question: Insights on life sciences segment - The life sciences segment experienced low single-digit growth, with expectations for normalization as government funding uncertainties resolve [60][61] Question: Order activity in municipal and industrial water - Management reported double-digit growth in municipal water orders in Q4, with confidence in sustainable mid-single-digit growth driven by critical infrastructure needs [90][91]